Kodiak Sciences Inc. KOD
Super Investor & Insider
1
Fondi che lo detengono
#1287
Rank consenso
1.4%
% dei portafogli
$1.6M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0.01% | Add 0.03% | 41,354 | $1.6M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of novel therapeutics for retinal diseases. The company specializes in next-generation therapies targeting chronic, high-prevalence ophthalmic conditions that lead to vision loss, including wet…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees130
TickerKOD
Statistics
Market Cap$2.23B
Revenue (TTM)$0
Net Income-$230.0M
Net Margin—
EPS$-4.32
P/E-7.86
P/S—
P/B18.79
EV/EBITDA-9.16
ROE-208.8%
Dividend Yield—
Price$35.84
Data: Twelve Data · Revenue = mcap / P/S